Walgreens will buy Fred’s pharmacy patient prescription files and related pharmacy inventory for $165 million.
Category: Forbes
Study: More Than 14,000 Americans Die Each Year From This Preventable Cancer
A new study reveals that 28% of deaths from colon-cancer could be prevented every year if all doctors and hospitals matched the screening rates of America’s highest-performing health systems.
Belviq Study Results May Improve The Fortunes Of Weight-Loss Drugs
Findings from a recently released post-marketing study on Belviq may remove some of the doubts concerning adverse events. And, effectiveness data lend support to the notion that Belviq in combination with behavioral therapies may be worth the money.
Biotech Venture Deal Terms Are More “Startup-Friendly” Than Ever
Biotech is booming, and that’s having an impact on deal terms. The author highlights a few observations from the Venture Financing Report of law firm Cooley LLP: money is flowing, valuations are up across the board, and deal terms are “looser” than the…
Generosity Isn’t Just About Doing Good, It’s Also Good For Our Mental Health, Suggests New Study
The science suggesting that generosity is a well-being-enhancing brain booster is getting stronger – now a new study reveals that the type of generosity makes a difference in how our brains respond.
What I Learned From Outdoors Camp For Adults
Here is a campy suggestion. Try an outdoors camp for adults, like The Outbound’s Pursuit Series, and see what it can do for your body, mind, and job.
What Amazon Did This Week
Amazon was worth 1 Trillion dollars briefly this week but what else happened on Planet Amazon? Here’s what.
How Republicans Opposed To Medicaid Expansion Hurts Children
The uninsured rate for children in dropped in Medicaid expansion states to 4% from 6% from 2013 to 2015 and has sustained such gains, new Urban Institute research shows.
Here Is How Much Sexting Among Teens Has Increased
What percentage of teens sext? How does this compare to adults?
Pharma Billionaire Charged With Penny Stock Fraud
Miami’s Phillip Frost, who built a $2.8 billion fortune in the generic drug business, was allegedly involved in a tawdry stock promotion scheme, the Securities and Exchange Commission says.
